Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Oderda

Showing results (161-170 of 175) with videos related to

Pageof 18
Sort By:
European Urology Oncology|January 25, 2024
The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by Magnetic Resonance Imaging-targeted Prostate BiopsyHenri-Alexandre Bourgeno, Teddy Jabbour, Arthur Baudewyns, et al.
World Journal of Urology|May 15, 2024
The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging scoreArthur Baudewyns, Karsten Guenzel, Adam Halinski, et al.
World Journal of Urology|March 15, 2023
Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approachMichael Baboudjian, Alberto Breda, Thierry Roumeguère, et al.
BJU International|October 16, 2015
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-GuérinPaolo Gontero, Richard Sylvester, Francesca Pisano, et al.
Prostate Cancer and Prostatic Diseases|July 24, 2024
Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesionsGeorges Mjaess, Laura Haddad, Teddy Jabbour, et al.
World Journal of Urology|June 12, 2024
External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratificationRomain Diamand, Karsten Guenzel, Teddy Jabbour, et al.
The Journal of Urology|May 11, 2019
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic ApproachesPaolo Gontero, Giancarlo Marra, Paolo Alessio, et al.
European Urology|July 22, 2014
Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patientsPaolo Gontero, Richard Sylvester, Francesca Pisano, et al.
Urologic Oncology|January 13, 2021
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective studyGiancarlo Marra, Robert Jeffrey Karnes, Giorgio Calleris, et al.
Minerva Urology and Nephrology|January 13, 2021
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy SocietyGiancarlo Marra, Maria P Laguna, Jochen Walz, et al.
Pageof 18

Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
European Urology Oncology|January 25, 2024
The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by Magnetic Resonance Imaging-targeted Prostate BiopsyHenri-Alexandre Bourgeno, Teddy Jabbour, Arthur Baudewyns, et al.
World Journal of Urology|May 15, 2024
The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging scoreArthur Baudewyns, Karsten Guenzel, Adam Halinski, et al.
World Journal of Urology|March 15, 2023
Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approachMichael Baboudjian, Alberto Breda, Thierry Roumeguère, et al.
BJU International|October 16, 2015
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-GuérinPaolo Gontero, Richard Sylvester, Francesca Pisano, et al.
Prostate Cancer and Prostatic Diseases|July 24, 2024
Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesionsGeorges Mjaess, Laura Haddad, Teddy Jabbour, et al.
World Journal of Urology|June 12, 2024
External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratificationRomain Diamand, Karsten Guenzel, Teddy Jabbour, et al.
The Journal of Urology|May 11, 2019
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic ApproachesPaolo Gontero, Giancarlo Marra, Paolo Alessio, et al.
European Urology|July 22, 2014
Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patientsPaolo Gontero, Richard Sylvester, Francesca Pisano, et al.
Urologic Oncology|January 13, 2021
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective studyGiancarlo Marra, Robert Jeffrey Karnes, Giorgio Calleris, et al.
Minerva Urology and Nephrology|January 13, 2021
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy SocietyGiancarlo Marra, Maria P Laguna, Jochen Walz, et al.
Pageof 18